Brain Diseases  >>  Cerebrolysin (porcine brain-derived proteolytic peptide fraction)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cerebrolysin (porcine brain-derived proteolytic peptide fraction) / Novartis, EVER Pharma
CASTA, NCT00868283: The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke

Completed
4
1071
RoW
Cerebrolysin, 0.9% Saline Solution, NaCl
Ever Neuro Pharma GmbH, Excel PharmaStudies, Inc., idv Datenanalyse und Versuchsplanung
Ischemic Stroke
10/10
02/11
DAT, NCT01822951 / 2012-004944-31: Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type

Withdrawn
4
0
Europe
Cerebrolysin, Cognicer, Renacenz, Donepezil, Other names:, e.g. Aricept, Donesyn
Ever Neuro Pharma GmbH
Alzheimer Disease
09/16
12/16

Download Options